Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0614941B2 - Multi-branch vascular prosthesis for coronary artery bypass - Google Patents
[go: Go Back, main page]

JPH0614941B2 - Multi-branch vascular prosthesis for coronary artery bypass - Google Patents

Multi-branch vascular prosthesis for coronary artery bypass

Info

Publication number
JPH0614941B2
JPH0614941B2 JP60041738A JP4173885A JPH0614941B2 JP H0614941 B2 JPH0614941 B2 JP H0614941B2 JP 60041738 A JP60041738 A JP 60041738A JP 4173885 A JP4173885 A JP 4173885A JP H0614941 B2 JPH0614941 B2 JP H0614941B2
Authority
JP
Japan
Prior art keywords
diameter
blood vessel
coronary artery
branch
bypass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60041738A
Other languages
Japanese (ja)
Other versions
JPS61199854A (en
Inventor
靖 城
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP60041738A priority Critical patent/JPH0614941B2/en
Publication of JPS61199854A publication Critical patent/JPS61199854A/en
Publication of JPH0614941B2 publication Critical patent/JPH0614941B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Prostheses (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は大動脈−冠状動脈バイパス用人工血管に関す
る。
Description: TECHNICAL FIELD The present invention relates to an artificial blood vessel for aorta-coronary artery bypass.

〔発明の概要〕[Outline of Invention]

本発明は、大動脈−冠状動脈バイパス用人工血管におい
て、口径6mm〜20mmの端部を有する大口径部と、これ
に内腔が連通しかつ枝分かれした支管とが一体に成形さ
れ、前記支管の先端の口径が口径1mm〜4mmとなるよう
に前記支管にテーパーを有する部分を存在させることに
よって血管の狭搾や閉塞が生じないようにしたものであ
る。
The present invention relates to an artificial blood vessel for aorta-coronary artery bypass, wherein a large-diameter portion having an end portion having a diameter of 6 mm to 20 mm and a branch pipe having an inner cavity communicating with and branching from the large-diameter portion are integrally formed, and the distal end of the branch pipe is formed. By providing a portion having a taper in the branch pipe so that the caliber has a caliber of 1 mm to 4 mm, narrowing or blockage of the blood vessel is prevented.

〔従来の技術〕[Conventional technology]

医療の発達が著しい昨今でも、心臓病による死亡は年々
増加して、米国では死因の第1位、日本でも死因の第3
位を占め、しかも年々増加の傾向がある。米国において
は心臓疾患のうち冠状動脈疾患で死亡する人は年間55
万人に達し、その大部分が冠状動脈の狭搾によるといわ
れている。このような人々を救うために米国では大動脈
−冠状動脈バイパス手術が毎年20万件以上も行われて
いる。通常大動脈−冠状動脈バイパスには患者の伏在静
脈を移殖するが、その主たる理由は、現在市販の人工血
管では冠状動脈バイパスに用いる口径5mm乃至それ以下
のものでは、早期に血管の狭窄や閉塞を生じてしまうか
らである。
Even with the recent remarkable development of medical care, the number of deaths due to heart disease has been increasing year by year, making it the leading cause of death in the United States and the third leading cause of death in Japan.
Occupies the top rank and tends to increase year by year. 55 heart disease deaths per year in the US
It is said to have reached the number of all, most of which is due to the narrowing of the coronary arteries. To save these people, more than 200,000 aortic-coronary bypass operations are performed each year in the United States. Usually, the saphenous vein of the patient is transplanted to the aorta-coronary artery bypass, the main reason for this is that with commercially available artificial blood vessels with a diameter of 5 mm or less used for coronary artery bypass, vascular narrowing or This is because it causes blockage.

従って、患者自身の伏在静脈を移植し、これによってか
なりの成功を納めているのがが現状である。
Therefore, the current situation is to transplant the patient's own saphenous vein, which has achieved considerable success.

〔発明が解決しようとする問題点〕[Problems to be solved by the invention]

しかしながら、大動脈−冠状動脈バイパスとして伏在静
脈の移植手術に成功した患者も、4年〜6年で移植した
血管が再び狭窄し、再手術を行わねばならないようにな
って来ている。このような場合、患者は最初の手術で自
家伏在静脈を使っているので再手術に必要な静脈がもは
やない。従ってこのような患者は再手術不能となり救命
の道を絶たれることになる。
However, patients who have succeeded in transplantation of the saphenous vein as an aorta-coronary artery bypass have come to have to perform re-operation again after the transplanted blood vessels have narrowed in 4 to 6 years. In such a case, the patient is using the saphenous autologous vein in the first operation and no more veins are needed for reoperation. Therefore, such a patient cannot be re-operated and the lifesaving route is cut off.

又冠状動脈疾患患者のかなりの数が伏在血管の質が悪か
ったり、使用可能なものが全くなかったり、あるいは十
分な長さが得られなかったりするために大動脈−冠状動
脈バイパス用血管が得られない。従って、このような患
者救命の道が閉ざされている。
In addition, a significant number of patients with coronary artery disease have poor quality of the saphenous vessels, none are available, or sufficient length cannot be obtained, so a blood vessel for aorta-coronary artery bypass is obtained. I can't. Therefore, such a life-saving method for patients is closed.

本発明者はこのような患者を救命するために良質の大動
脈−冠状動脈バイパス用移植材の開発を進め、本発明に
到達した。
The present inventor has advanced the development of a good quality aortic-coronary artery bypass graft material in order to save the life of such a patient, and arrived at the present invention.

人工血管は現在主としてポリエステル繊維の編織物によ
る人工血管と、弗素樹脂で延伸フィブリル化したいわゆ
るPTFE(ポリテトラフルオロエチレン)を素材とす
るものが用いられている。
Currently, artificial blood vessels mainly made of knitted and woven polyester fibers and those made of so-called PTFE (polytetrafluoroethylene), which is stretched and fibrillated with a fluororesin, are used.

そしてこれらの人工血管は移植後、血漿蛋白の吸着、血
小板の沈着、凝固因子賦活、フィブリン析出を経、更に
析出されたフィブリンが細胞で置換され、これを基盤と
して仮性内膜、線維性外膜が形成されることによって生
体化されるが、このためには人工血管が適度なポロシテ
ィ(有孔性)を有することが要である。しかし大動脈−
冠状動脈バイパス用としての血管には内口径が5mm以
下、通常4mm〜3mmの人工血管が要とされ、従来の5mm
以下の人工血管では移植後、血管の狭窄、閉塞をおこさ
ないと言ってよい。
After transplantation, these artificial blood vessels undergo plasma protein adsorption, platelet deposition, coagulation factor activation, and fibrin deposition, and the deposited fibrin is replaced by cells. The artificial blood vessel is required to have an appropriate porosity (porosity). But the aorta-
A blood vessel for bypassing the coronary artery requires an artificial blood vessel with an inner diameter of 5 mm or less, usually 4 mm to 3 mm.
It can be said that the following artificial blood vessels do not cause stenosis or blockage of blood vessels after transplantation.

本発明者はこの狭窄、閉塞が生じる原因の大部分が宿主
血管との吻合部に起因し、吻合の良し悪しが移植人工血
管の開存の成績に大きい影響を与えることを知った。
The inventor has found that most of the causes of the stenosis and occlusion are caused by the anastomosis with the host blood vessel, and whether the anastomosis is good or bad has a great influence on the results of patency of the transplanted artificial blood vessel.

〔問題点を解決するための手段〕[Means for solving problems]

吻合の手技は術者の縫合技術に優劣があるのは当然であ
るが、縫合する血管の径が細くなる程、吻合が難しいこ
とは論をまたない。本発明は大動脈−冠状動脈バイパス
用の人工血管の開発について鋭意研究を進め、移植血管
の開存率を向上させるために、一端の吻合物の口径を、
すなわち上行大動脈へ吻合する側の端を口径6mm〜20
mmとし、この比較的太い血管より2支、3支、4支と枝
分かれさせて、この支管の端を、移植する冠状動脈の太
さに見合うように口径1mm〜4mmとすることを案出して
本発明に至ったものである。
Obviously, the technique of anastomosis has superiority and inferiority to the operator's suturing technique, but it goes without saying that as the diameter of the blood vessel to be sutured becomes smaller, the anastomosis is more difficult. The present invention advances earnest research on the development of an artificial blood vessel for aorta-coronary artery bypass, and in order to improve the patency of the transplanted blood vessel, the diameter of the anastomosis at one end is
That is, the end on the side of anastomosis to the ascending aorta is 6 mm to 20 mm in diameter.
mm, branching into 2 branches, 3 branches, and 4 branches from this relatively thick blood vessel, and devising to make the end of this branch tube 1 mm to 4 mm in diameter to match the thickness of the coronary artery to be transplanted. The present invention has been achieved.

大動脈−冠状動脈バイパス用血管としては現在、患者の
伏在静脈が用いられている。大抵の場合、患者の伏在静
脈ないし大腿静脈から適当な長さの血管を切とり、これ
を大動脈−冠状動脈バイパス用血管に使用するが、冠状
動脈狭窄の患者は通常ひとつにバイパスですむ場合より
2支、3支のバイパスを行わねばならぬ場合が多い。
The saphenous vein of the patient is currently used as a blood vessel for aorta-coronary artery bypass. In most cases, an appropriate length of blood vessel is cut from the patient's saphenous or femoral vein and used as a blood vessel for aortic-coronary artery bypass, but for patients with coronary stenosis, usually only one bypass is required. In many cases, it is necessary to bypass two or three branches.

第5図に従来の2支バイパスの例を示した。通常バイパ
ス手術は2支バイパス、3支バイパスが多い。この場
合、口径3mm〜4mmの細い血管を大動脈にも2回、2場
所に縫合しなくてはならない。そのために上行大動脈の
相当の場所を吻合物で占められる。このような場合、患
者に更に補助人工心臓を適用して救命しようとしても、
人工心臓の大動脈側の拍出血液を導入するカニューレを
挿入する場所がなく、補助心臓を適用することも出来な
くなる。又この方法の場合、移植血管は細いので吻合技
術が難しくて、縫合不手際による血栓発生の可能性が大
きくなる。又、2支、3支バイパスのときは同じ操作を
2度、3度と繰返さなければならないので2重、3重の
手間が要り、それだけ患者の負担が大きくなる。
FIG. 5 shows an example of a conventional two-support bypass. In most cases, bypass surgery usually involves two or three branches. In this case, a thin blood vessel having a diameter of 3 mm to 4 mm must be sutured to the aorta twice at two places. Therefore, an anastomosis occupies a considerable area of the ascending aorta. In such a case, even if you try to save life by applying a supplemental artificial heart to the patient,
There is no place to insert a cannula for introducing the pumped blood on the aorta side of the artificial heart, and it becomes impossible to apply the auxiliary heart. Further, in this method, since the transplanted blood vessel is thin, the anastomosis technique is difficult, and the possibility of thrombus generation due to inadequate suturing increases. Further, in the case of a two-support and three-support bypass, the same operation has to be repeated twice or three times, which requires double or triple labor, which increases the burden on the patient.

本発明者はこれらの問題点を解決し、術者にとってやり
易く、患者の負担を軽減し、かつ移植後のトラブルの少
ない人工血管を開発しよう種々の検討を行って本発明に
到達したものであり、その要旨は、大動脈−冠状動脈バ
イパス用の人工血管であって、口径6mm〜20mmの端部
を有する大口径部と、これに内腔が連通しかつ枝分かれ
した複数の支管とが一体に成形され、前記支管の先端が
比較的小口径となるように、大口径部と前記支管の先端
との間にテーパーを有する部分を存在させることを特徴
とする冠状動脈バイパス用多支人工血管である。
The present inventors have reached the present invention by conducting various studies to solve these problems, to develop an artificial blood vessel that is easy for an operator, reduces the burden on the patient, and has less trouble after transplantation. The main point is an artificial blood vessel for aorta-coronary artery bypass, in which a large-diameter portion having an end portion with a diameter of 6 mm to 20 mm and a plurality of branch pipes with which the lumen communicates and branches A multi-branch artificial blood vessel for coronary artery bypass, characterized by having a tapered portion between the large diameter portion and the end of the branch pipe so that the end of the branch pipe has a relatively small diameter. is there.

本発明の支管の数は2〜6の間であって、好ましくは2
〜4、更に好ましくは2又は3である。本発明の人工血
管は、大動脈に縫合する部分が、内口径6mm〜20mmで
あり、好ましくは8mm〜15mm、更に好ましくは9mm〜
13mmである。即ち6mm以下だと凝血層で内腔が狭くな
ることが吻合手技が難しいこともあり、又20mmをいえ
ると逆に大動脈への縫合が難しく又太すぎてかえって好
ましくないからである。
The number of branch pipes according to the invention is between 2 and 6, preferably 2
-4, more preferably 2 or 3. In the artificial blood vessel of the present invention, the portion to be sutured to the aorta has an inner diameter of 6 mm to 20 mm, preferably 8 mm to 15 mm, more preferably 9 mm to
It is 13 mm. That is, if it is less than 6 mm, it may be difficult for the anastomosis technique to narrow the lumen in the blood clot, and if it is more than 20 mm, it is difficult to suture to the aorta and is too thick, which is not preferable.

本発明による血管は、冠状動脈移植側へ向かって口径を
細くするが、全長に亘って実質的に均一にテーパをつけ
てもよく、又一定長さまで比較的大口径のまま連なり、
途中から先細りテーパーとなってよく、あるいは大動脈
吻合側より冠状動脈吻合側に至る間のどの場所にテーパ
ーを有しても良い。冠状動脈側の支管の先端の口径は1
mm〜4mm、好ましくは2mm〜3mmである。これにより細
くても太くても冠状動脈への吻合が難しく、その不手際
が原因で移植血管が閉塞することが多い。
The blood vessel according to the present invention has a narrower diameter toward the side of the coronary artery graft, but may be tapered substantially uniformly over the entire length, or may continue to have a relatively large diameter up to a certain length,
The taper may be tapered from the middle, or may be tapered anywhere from the aortic anastomosis side to the coronary anastomosis side. The diameter of the end of the branch tube on the coronary artery side is 1
It is from mm to 4 mm, preferably from 2 mm to 3 mm. As a result, anastomosis to the coronary arteries is difficult regardless of whether it is thin or thick, and the graft vessel is often occluded due to its inadequacy.

第1図に本発明の第1の例を示す。FIG. 1 shows a first example of the present invention.

この例は2つに枝分かれした2支血管である。大口径部
は口径Lが10mmであり、この太さは枝分かれ部まで
続いている。この枝分かれの様態が実は非常に大切であ
り、内腔を形成する内表面に全く段差がなく滑らかに連
なっていることが必要で、この支管のなす角度θ(第1
図)は90゜以下、好ましくは70゜以下、更に好まし
くは60゜がよい。θは又10゜以上であることが望ま
しい。内腔面は段差のない滑らかなものでなければなら
ない。本例では大口径側の口径Lは10mmであるが、
枝分かれする部分の最長径Lは膨らんで16mmになっ
ており、内径lが8mmの管2本に枝分かれしており枝
分かれ後の支管は先細テーパーA、Aとなってお
り、最先端では口径lが2mmであり、支管の長さは1
3cmである。
An example of this is a bifurcated blood vessel that is bifurcated. The large diameter portion has a diameter L 1 of 10 mm, and this thickness continues to the branch portion. This branching is actually very important, and it is necessary that the inner surface forming the lumen has no step and is smoothly connected. The angle θ (first
In the figure, 90 ° or less, preferably 70 ° or less, more preferably 60 °. It is desirable that θ is 10 ° or more. The luminal surface must be smooth with no steps. In this example, the diameter L 1 on the large diameter side is 10 mm,
The longest diameter L 2 of the branching portion is inflated to 16 mm, and the branching pipe after branching has two tapered tapers A 1 and A 2 with an inner diameter l 1 of 8 mm. Has a diameter l 2 of 2 mm and a branch pipe length of 1
It is 3 cm.

第2図は本発明の第2の例を示す。本例は3つに枝分か
れした3支血管であり、大口径側の先端口径Lは12
mmであり、この先端より5cmのところで3支に枝分かれ
しており、この枝分かれ点では口径Lは最長径21mm
であり、枝分かれした支管の口径lは夫々7mmφであ
る。この7mmφの管の長さは約35mmあり、それより先
は先細りテーパーA,A,Aになっていて、支管
の先端の口径lは2mmであり、支管の長さは夫々15
cmである。支管は滑らかに同一方向に曲率を有していて
バイパス手術に都合のよいように工夫されている。
FIG. 2 shows a second example of the present invention. In this example, there are three branch blood vessels branched into three, and the tip diameter L 3 on the large diameter side is 12
mm, and it is branched into 3 branches at 5 cm from this tip, and at this branch point, the diameter L 4 is 21 mm at the longest.
The caliber l 3 of the branched branch pipes is 7 mmφ. The 7 mmφ pipe has a length of about 35 mm, and the tapered pipes A 3 , A 4 , and A 5 have tapered ends, and the diameter l 4 of the tip of the branch pipe is 2 mm, and the length of each branch pipe is 15 mm.
cm. The branch tubes have a smooth curvature in the same direction and are designed to be convenient for bypass surgery.

第3図に本発明の第3の例をあげる。本例も3つに枝分
かれする3支血管であるが、第2の例と異なり、分枝点
が2つあり、ひとつの分枝点でひとつずつ支管を形成し
ているものである。本例では先細テーパーA,A
は各支管の途中、支管の真中あたりに設けられてお
り、両端は一定口径のものである。この方式での分枝は
血管内を流れる血流に無理がなく好ましいものである。
FIG. 3 shows a third example of the present invention. This example also has three branch vessels that branch into three, but unlike the second example, there are two branch points, and each branch point forms a branch tube. In this example, the tapered tapers A 6 , A 7 ,
A 8 is the middle of the branch pipes is provided per the middle of the branch pipe, both ends are of constant diameter. Branching in this manner is preferable because there is no difficulty in the blood flow in the blood vessel.

ここに例示した第2図及び第3図の枝分かれした多支管
は滑らかな曲線をもって同じ方向にたわんでいる。この
ように適度の曲率をもたせると、手術する患者の心臓に
沿ってバイパス手術がし易く便利である。
The branched multi-branch tubes of FIGS. 2 and 3 illustrated here are bent in the same direction with smooth curves. Such an appropriate curvature facilitates bypass surgery along the heart of the patient to be operated, which is convenient.

なお、枝分かれした支管のテーパー部分は第1図の
、A、第2図のA、A、Aの如く枝分かれ
点から最先端にかけてテーパ状に形成されていてもよ
く、第3図のA、A、Aの如く支管の枝分かれ点
と最先端との中間部分をテーパー状に形成してもよい。
The tapered portion of the branched branch pipe may be formed in a tapered shape from the branching point to the tip as shown by A 1 , A 2 in FIG. 1 , and A 3 , A 4 , A 5 in FIG. The intermediate portion between the branch point and the tip of the branch pipe may be formed in a taper shape as indicated by A 6 , A 7 , and A 8 in FIG.

なお、第1図のA、A、第2図のA、A
、第3図のA、A、Aで示されるテーパー部
分の長さをAとすると、このテーパー部分の長さA
と大口径側の長さl(第1図〜第8図に示すl)と
は 4l≧A≧l/4 の関係であることが望ましい。
Note that A 1 , A 2 in FIG. 1 and A 3 , A 4 , in FIG.
A 5, if the length of the tapered portion indicated by A 6, A 7, A 8 of FIG. 3 and A x, length A x of the tapered portion
And it is desirable that the length l 0 of the large diameter side (l 0 shown in FIG. 1-FIG. 8) is the relationship 4l 0 ≧ A x ≧ l 0 /4.

もし、テーパー部分の長さAがl/4より短い(テ
ーパーが急である)と血流速がそのテーパー部分におい
て急激に変化し、人工血管内面に形成された細胞の剥離
を生じるなどしてこの為に血栓生成の原因となることが
ある。
If the length A x of the tapered portion (a steep taper) shorter than l 0/4 and abrupt changes in blood flow velocity taper portion thereof, such as resulting in exfoliation of cells formed in the artificial blood vessel inner surface As a result, it may cause thrombus formation.

また、必要とされる人工血管全体の長さはある程度限定
される長さであるのでその全長のうちでテーパー部分の
長さAを大口径側の長さlに対して4lよりも長
くすると人工血管全体に対して大口径側の長さが短くな
り宿主血管への吻合が極めて困難となる。
Further, since the required total length of the artificial blood vessel is limited to some extent, the length A x of the taper portion of the total length of the artificial blood vessel is more than 4l 0 with respect to the length l 0 on the large diameter side. If the length is increased, the length on the large diameter side of the entire artificial blood vessel becomes short, and it becomes extremely difficult to anastomose the host blood vessel.

第4図に本発明の人工血管の1実施様態を示す。FIG. 4 shows one embodiment of the artificial blood vessel of the present invention.

本発明に用いられる人工血管の材質はポリエステル繊維
の編織物、延伸フィブリル化した弗化樹脂製のもの、ポ
リウレタン製のもの、またポリプロピレン、ポリエチレ
ン、ポリビニルアルコール等の不織布で出来ていてもよ
い。又これらの人工血管は抗血栓材で加工して用いても
よいことは言うまでもない。
The material of the artificial blood vessel used in the present invention may be a knitted fabric of polyester fibers, a product made of stretched fibrillated fluororesin, a product made of polyurethane, or a non-woven fabric made of polypropylene, polyethylene, polyvinyl alcohol or the like. Needless to say, these artificial blood vessels may be processed with an antithrombotic material before use.

〔実施例〕〔Example〕

第1図及び第3図のセグメントポリウレタン製の人工血
管を形成した。大動脈吻合側の口径は9mm、冠状動脈側
の口径は3mmであった。これを山羊を用いてモデル的に
大動脈−冠状動脈バイパスを行ったところ3ケ月後も完
全に開存していた。一方、同じ素材で全長に亘って口径
が3mmである比較サンプルを用いて同じようにバイパス
を形成したところ、1ケ月で狭窄を生じ、2ケ月で閉塞
した。
An artificial blood vessel made of the segmented polyurethane of FIGS. 1 and 3 was formed. The diameter of the aortic anastomosis side was 9 mm, and the diameter of the coronary artery side was 3 mm. When this was subjected to model aortic-coronary bypass using a goat, it was completely patent even after 3 months. On the other hand, when a bypass was formed in the same manner using a comparative sample made of the same material and having a diameter of 3 mm over the entire length, stenosis occurred in one month and occlusion occurred in two months.

〔発明の効果〕〔The invention's effect〕

本発明の効果を挙げると次の通りである。 The effects of the present invention are as follows.

(1)大動脈に吻合する部分が大口径になっているので
吻合し易い。これによって吻合部に歪がなく、大動脈と
の吻合部に起因するトラブルが激減する。
(1) Since the part to be anastomosed to the aorta has a large diameter, it is easy to make an anastomosis. As a result, the anastomosis is not distorted, and the trouble caused by the anastomosis with the aorta is drastically reduced.

(2)多支バイパスであっても大動脈側の吻合は一回で
よい。
(2) The anastomosis on the aortic side may be performed only once even in the multi-branch bypass.

(3)大動脈側の吻合血管が太いため閉塞することはな
い。
(3) Since the anastomotic blood vessel on the aortic side is thick, it will not be blocked.

(4)移植血管の可なりの部分が大口径なので閉塞や狭
窄をおこさないばかりでなく、その間の圧力損失が少な
く、支管の先端まで高血圧を保てるので、先の細い部分
も血栓を生じない。
(4) Since a large diameter of the transplanted blood vessel has a large diameter, it does not cause occlusion or stenosis, and there is little pressure loss during that time, and high blood pressure can be maintained up to the tip of the branch pipe, so that even a narrowed portion does not cause thrombosis.

(5)テーパー効果で先(冠状動脈側)に至る程血流速
が増すので、冠状動脈吻合部にも血栓による狭窄ないし
閉塞を生じない。
(5) Since the blood flow velocity increases toward the tip (on the side of the coronary artery) due to the taper effect, stenosis or occlusion due to thrombus does not occur at the anastomosis site of the coronary artery.

(6)冠状動脈の太さに応てテーパーの先端を切って所
望の太さの先端を得ることが出来る。
(6) The tip of the taper can be cut according to the thickness of the coronary artery to obtain the tip with a desired thickness.

本発明によって大動脈−冠状動脈バイパス用の人工血管
の実用化への道が開かれたのであるから、これまで手術
不能で救命不能であった多くの患者を救命する扉を開い
たことになる。
Since the present invention has paved the way for the practical application of an artificial blood vessel for aortic-coronary artery bypass, it has opened the door to save many patients who were inoperable and unable to save lives up to now.

【図面の簡単な説明】[Brief description of drawings]

図面において、第1図は本発明における大動脈−冠状動
脈バイパス用2支人工血管の1例を示す図、第2図は本
発明における大動脈−冠状動脈バイパス用3支人工血管
の1例を示す図、第3図は本発明における大動脈−冠状
動脈バイパス用3支人工血管の他の1例を示す図、第4
図は本発明の大動脈−冠状動脈バイパス用人工血管の実
施様態を示す図、第5図は従来行なわれている伏在静脈
の大動脈−冠状動脈バイパス移植手術の様態を示す図で
ある。 なお図面に用いた符号において、 1……上行大動脈 2……肺動脈 3……左心房 4,5……左冠状動脈 6……右冠状動脈 7,7′……狭窄部 8……バイパス用人工血管 9,10……バイパス血管 である。
In the drawings, FIG. 1 is a diagram showing one example of an aorta-coronary artery bypass bifurcated artificial blood vessel in the present invention, and FIG. 2 is a diagram showing an example of an aorta-coronary artery bypass trifurcated artificial blood vessel in the present invention. FIG. 3 is a diagram showing another example of the trifurcated artificial blood vessel for aorta-coronary artery bypass according to the present invention, FIG.
FIG. 1 is a diagram showing an embodiment of an artificial blood vessel for aorta-coronary artery bypass of the present invention, and FIG. 5 is a diagram showing an embodiment of a conventional saphenous vein aorta-coronary artery bypass graft surgery. In the reference numerals used in the drawings, 1 ... Ascending aorta 2 ... Pulmonary artery 3 ... Left atrium 4,5 ... Left coronary artery 6 ... Right coronary artery 7, 7 '... Stenosis 8 ... Bypass artificial Blood vessels 9, 10 ... Bypass vessels.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】口径6mm〜20mmの端部を有する大口径部
と、これに内腔が連通しかつ枝分かれした2つ以上の支
管とが一体に成形され、前記支管の先端が口径1mm〜4
mmとなるように大口径部と前記支管の先端との間にテー
パーを有する部分を存在させることを特徴とする冠状動
脈バイパス用多支人工血管。
1. A large-diameter portion having an end portion having a diameter of 6 mm to 20 mm and two or more branch pipes having an inner cavity communicating with and branched from the large-diameter portion are integrally formed, and the tip of the branch pipe has a diameter of 1 mm to 4 mm.
A multi-branch artificial blood vessel for coronary artery bypassing, wherein a tapered portion is present between the large diameter portion and the tip of the branch tube so that the diameter becomes mm.
JP60041738A 1985-03-01 1985-03-01 Multi-branch vascular prosthesis for coronary artery bypass Expired - Lifetime JPH0614941B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60041738A JPH0614941B2 (en) 1985-03-01 1985-03-01 Multi-branch vascular prosthesis for coronary artery bypass

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60041738A JPH0614941B2 (en) 1985-03-01 1985-03-01 Multi-branch vascular prosthesis for coronary artery bypass

Publications (2)

Publication Number Publication Date
JPS61199854A JPS61199854A (en) 1986-09-04
JPH0614941B2 true JPH0614941B2 (en) 1994-03-02

Family

ID=12616764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60041738A Expired - Lifetime JPH0614941B2 (en) 1985-03-01 1985-03-01 Multi-branch vascular prosthesis for coronary artery bypass

Country Status (1)

Country Link
JP (1) JPH0614941B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187033B1 (en) 1997-09-04 2001-02-13 Meadox Medicals, Inc. Aortic arch prosthetic graft

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6031743A (en) * 1983-07-29 1985-02-18 日本ゼオン株式会社 Blood bypassing tube

Also Published As

Publication number Publication date
JPS61199854A (en) 1986-09-04

Similar Documents

Publication Publication Date Title
AU572819B2 (en) Vascular graft and blood supply method
Gazzaniga et al. Arterial prosthesis of microporous expanded polytetrafluoroethylene for construction of aorta-pulmonary shunts
US6283983B1 (en) Percutaneous in-situ coronary bypass method and apparatus
US5078735A (en) Prosthetic grafting method for bypass surgery
US5314468A (en) Aortic valved tubes for human implants
US4769029A (en) Prosthetic graft for arterial system repair
Kabbani et al. Sequential internal mammary-coronary artery bypass
Kenney et al. Comparison of noncrimped, externally supported (EXS) and crimped, nonsupported Dacron prostheses for axillofemoral and above-knee femoropopliteal bypass
Helseth et al. Results of composite graft replacement for aortic root aneurysms
Edwards Arterial grafts: past, present, and future
US20060190017A1 (en) Fibrin sealants and platelet concentrates applied to effect hemostasis at the interface of an implantable medical device with body tissue
US20090024208A1 (en) Stent
Moor et al. Surgical repair of coarctation of the aorta by patch grafting
Sewell et al. Technique for the coronary snake graft operation
JPH0614941B2 (en) Multi-branch vascular prosthesis for coronary artery bypass
Haimov Clinical experience with the expanded polytetrafluoroethylene vascular prosthesis
Emery et al. First clinical use of the Possis® synthetic coronary graft
JP2001502205A (en) Vascular graft
Uretzky et al. Modified Fontan procedure in patients with previous ascending aorta-pulmonary artery anastomosis
JPH05500912A (en) polymer products
Harashina et al. A new anastomosis technique for large‐calibered vein grafts
RU2066124C1 (en) Method of arterioplasty
Yamashita et al. Successful surgical treatment of a pseudoaneurysm after composite graft replacement of the aortic valve and ascending aorta: Report of two cases
Hvass et al. Tandem coarctation of the thoracic aorta: An unusual congenital anomaly
RU2716453C1 (en) Method for hybrid treatment of aortic aneurysm without artificial circulation with maintaining perfusion of cerebrum during transposition of branches of aortic arch